As both PDA and desmoplastic-type MM (a rare MM subtype characterized by a very poor patient prognosis) are characterized by excess ECM deposition, they may comprise good candidates for CTGF inhibitor treatment. The gene discussed is CCN2; the disease is Miyoshi myopathy.